# Roche Holding AG (RHHBY)

> Source: Nexqual · https://nexqual.com/RHHBY · data as of 2026-10-23 17:11 UTC · cite as "Nexqual, Roche Holding AG (RHHBY), nexqual.com/RHHBY" · informational, not investment advice.

**Price:** USD 60.16 (+0.91% today) · US market open, as of October 23, 2026 at 17:11 UTC; quotes may be delayed. Prev close 59.62 · day 59–61.45 · 52w 40.07–61.45 · market cap $383B · OQX

## Key facts
- Analysts: Hold (mean 2.50 on a 1–5 scale) (8 analysts), mean target USD 60.01 (range 52–67.1).
- Total return with dividends: 1Y +46.1% vs S&P 500 +14.4%; 5Y +47.3% vs S&P 500 +77.0%.

## Analysts
Consensus Hold (mean 2.50 on a 1–5 scale), 8 analysts; mean target USD 60.01 (low 52, high 67.1).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +46.1% | +47.3% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | +46.2% | +8.1% |
| Volatility (annualized) | 28.3% | 24.5% |
| Max drawdown | -19.3% (Feb 2026→Mar 2026) | -39.6% (Apr 2022→Apr 2024) |

## Peers (Drug Manufacturers - General)
MRK (Merck & Company, Inc.) USD 145.01 -1.51% · ABBV (AbbVie Inc.) USD 286.12 +0.32% · NVS (Novartis AG) USD 151.13 -3.29% · AZN (AstraZeneca PLC) USD 171.16 -0.82% · AMGN (Amgen Inc.) USD 441.32 -1.33% · JNJ (Johnson & Johnson) USD 263.27 -1.62%

## More
Full page: https://nexqual.com/RHHBY · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | — | — | — | $15.73B | — |
| Next quarter (ends 2026-12-31) | — | — | — | $16.60B | — |
| Current fiscal year (ends 2026-12-31) | $3.10 | $3.07 | +0.9% | $63.01B | 5 |
| Next fiscal year (ends 2027-12-31) | $3.33 | $3.38 | -1.3% | $66.09B | 5 |